CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VERA — Vera Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VERA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$23,386,507
+$2,283,378 QoQ
Shares Held
545,013
+3.9% QoQ
Ownership
0.756%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 217 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. VERA ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in VERA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,386,507 | 545,013 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $21,103,129 | 524,562 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $26,274,969 | 518,858 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $13,536,409 | 465,809 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $10,471,383 | 444,456 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,207,058 | 424,940 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $18,212,822 | 430,665 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $15,991,781 | 361,805 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $12,702,363 | 351,088 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,592,886 | 338,425 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $4,274,963 | 277,956 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,660,624 | 267,004 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,453,022 | 90,531 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $476,611 | 61,419 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $751,921 | 38,859 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $807,435 | 37,890 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $472,144 | 34,691 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $816,113 | 34,743 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $627,706 | 23,492 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $294,047 | 16,948 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||